Elanco Animal Health Inc. Receives USDA Approval for TruCan Ultra CIV Canine Influenza Vaccine, Enhancing Dog Respiratory Protection

Reuters

Jul 09

<a href="https://laohu8.com/S/ELAN">Elanco Animal Health Inc</a>. Receives USDA Approval for TruCan Ultra CIV Canine Influenza Vaccine, Enhancing Dog Respiratory Protection

Elanco Animal Health Inc. has received approval from the U.S. Department of Agriculture (USDA) for its TruCan Ultra CIV H3N2/H3N8, a canine influenza vaccine. This vaccine offers broad respiratory protection against the H3N2 and H3N8 strains, making it the only ½ mL bivalent Canine Influenza Virus (CIV) vaccine available with such comprehensive coverage. With 100% virus neutralization against 33 current field isolates and zero lung lesions observed in vaccinated dogs post H3N2 challenge, TruCan Ultra CIV completes Elanco's Tru Portfolio of vaccines. This approval underscores Elanco's commitment to providing innovative animal health solutions, enhancing the health and happiness of pets and their owners.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE25259) on July 09, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2550313637"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2550313637\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2550313637?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-09 20:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2550313637","market":"us","top_or_hot":-1,"title":"Elanco Animal Health Inc. Receives USDA Approval for TruCan Ultra CIV Canine Influenza Vaccine, Enhancing Dog Respiratory Protection","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ELAN\">Elanco Animal Health Inc</a>. Receives USDA Approval for TruCan Ultra CIV Canine Influenza Vaccine, Enhancing Dog Respiratory Protection\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/ELAT\">Elanco Animal Health</a> Inc. has received approval from the U.S. Department of Agriculture (USDA) for its TruCan Ultra CIV H3N2/H3N8, a canine influenza vaccine. This vaccine offers broad respiratory protection against the H3N2 and H3N8 strains, making it the only ½ mL bivalent Canine Influenza Virus (CIV) vaccine available with such comprehensive coverage. With 100% virus neutralization against 33 current field isolates and zero lung lesions observed in vaccinated dogs post H3N2 challenge, TruCan Ultra CIV completes Elanco's Tru Portfolio of vaccines. This approval underscores Elanco's commitment to providing innovative animal health solutions, enhancing the health and happiness of pets and their owners.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE25259) on July 09, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elanco Animal Health Inc. Receives USDA Approval for TruCan Ultra CIV Canine Influenza Vaccine, Enhancing Dog Respiratory Protection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElanco Animal Health Inc. Receives USDA Approval for TruCan Ultra CIV Canine Influenza Vaccine, Enhancing Dog Respiratory Protection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-09 20:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ELAN\">Elanco Animal Health Inc</a>. Receives USDA Approval for TruCan Ultra CIV Canine Influenza Vaccine, Enhancing Dog Respiratory Protection\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/ELAT\">Elanco Animal Health</a> Inc. has received approval from the U.S. Department of Agriculture (USDA) for its TruCan Ultra CIV H3N2/H3N8, a canine influenza vaccine. This vaccine offers broad respiratory protection against the H3N2 and H3N8 strains, making it the only ½ mL bivalent Canine Influenza Virus (CIV) vaccine available with such comprehensive coverage. With 100% virus neutralization against 33 current field isolates and zero lung lesions observed in vaccinated dogs post H3N2 challenge, TruCan Ultra CIV completes Elanco's Tru Portfolio of vaccines. This approval underscores Elanco's commitment to providing innovative animal health solutions, enhancing the health and happiness of pets and their owners.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE25259) on July 09, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4561","symbol_name":"索罗斯持仓","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL4htnFm:1","article_id":"2550313637","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2550313637","pubTimestamp":1752064039,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Elanco Animal Health Inc. Receives USDA Approval for TruCan Ultra CIV Canine Influenza Vaccine, Enhancing Dog Respiratory Protection. Elanco Animal Health Inc. has received approval from the U.S. Department of Agriculture  for its TruCan Ultra CIV H3N2/H3N8, a canine influenza vaccine. This vaccine offers broad respiratory protection against the H3N2 and H3N8 strains, making it the only  mL bivalent Canine Influenza Virus  vaccine available with such comprehensive coverage. With 100% virus neutralization against 33 current field isolates and zero lung lesions observed in vaccinated dogs post H3N2 challenge, TruCan Ultra CIV completes Elanco's Tru Portfolio of vaccines. This approval underscores Elanco's commitment to providing innovative animal health solutions, enhancing the health and happiness of pets and their owners.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4561":"索罗斯持仓","BK4007":"制药","ELAN":"Elanco Animal Health Inc"},"translate_title":"Elanco Animal Health Inc.获得美国农业部批准TruCan Ultra CIV犬流感疫苗，增强狗的呼吸保护","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELAN":0.9},"content_text":"Elanco Animal Health Inc. Receives USDA Approval for TruCan Ultra CIV Canine Influenza Vaccine, Enhancing Dog Respiratory Protection\n    \n\nElanco Animal Health Inc. has received approval from the U.S. Department of Agriculture (USDA) for its TruCan Ultra CIV H3N2/H3N8, a canine influenza vaccine. This vaccine offers broad respiratory protection against the H3N2 and H3N8 strains, making it the only ½ mL bivalent Canine Influenza Virus (CIV) vaccine available with such comprehensive coverage. With 100% virus neutralization against 33 current field isolates and zero lung lesions observed in vaccinated dogs post H3N2 challenge, TruCan Ultra CIV completes Elanco's Tru Portfolio of vaccines. This approval underscores Elanco's commitment to providing innovative animal health solutions, enhancing the health and happiness of pets and their owners.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE25259) on July 09, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}